IC 27-13-38-2: Substitution of brand name drugs
Where this section sits in the code
- TITLE 27. INSURANCE
- ARTICLE 13. HEALTH MAINTENANCE ORGANIZATIONS
- Chapter 38. Patient Protection; Drugs and Devices; Drug Utilization Review Program
Sec. 2. Subject to IC 16-42-22:
(1) a pharmacist shall not substitute; and
(2) a health maintenance organization shall not require the substitution of;
a different single source brand name drug for a single source brand name drug written on a prescription form or electronically transmitted to a pharmacy unless the substitution is approved by the prescribing provider.
Collected 2026-09-25T05:39:04Z. Source file · JSON